Illumina

Sequencing Sales Specialist-Manhattan and Long Island

New York, New York, United States

Illumina Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Genomics, Life SciencesIndustries

Requirements

Candidates should possess a Bachelor’s degree and have at least 5 years of experience in sales, preferably within the scientific or medical device industry, with a strong preference for experience in sequencing or genomics sales. Demonstrated ability to build and maintain strong customer relationships is essential, along with a deep understanding of Illumina’s sequencing and multiomic product portfolios.

Responsibilities

The Senior Sequencing Sales Specialist will work closely with sales teams to achieve regional sales objectives, assist in developing territory plans, meet with customers individually and as a team, prepare and present technical seminars on Illumina Sequencing products, and develop long-term customer relationships as a trusted consultant. Additionally, the role involves leveraging technical knowledge to support sales, becoming an expert on new Illumina innovations, maintaining knowledge of market trends and competition, and assisting with workshops and marketing activities.

Skills

Technical knowledge of Illumina Sequencing products
Scientific research understanding
Clinical research understanding
Communication skills
Presentation skills
Customer relationship building
Sales support
Technical seminar presentation
Product and application training

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI